Peer-Reviewed Publication
Am J Hypertens2025;38(12):1009-1019.November 17, 2025Journal Article
AI in Hypertensive Disorders of Pregnancy: Review.
Ruben D Zapata1, Tioluwani Tolani2, Rebecca Reich3, Sophie Beneteau4, Hana Ali5, Tanmayee Kolli5, Michaela Rechdan6, Lindsey Brinkley6, Michele Himadi6, Adetola Louis-Jacques7,8, Francois Modave9, Steven M Smith6,10, Tony Wen7, Elizabeth Shenkman1, Dominick J Lemas1,7,8
1Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, Florida, USA.
2American University of the Caribbean School of Medicine, Cupecoy, Sint Maarten.
3Department of Food Science and Human Nutrition, College of Agricultural and Life Sciences, University of Florida, Gainesville, Florida, USA.
4Department of Mathematics, College of Liberal Arts and Sciences, University of Florida, Gainesville, Florida, USA.
5Department of Biomedical Engineering, Herbert Wertheim College of Engineering, Univerisity of Florida, Gainesville, Florida, USA.
6Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.
7Department of Obstetrics/Gynaecology, University of Florida, Gainesville, Florida, USA.
8College of Medicine, University of Florida Center for Perinatal Outcomes Research, Gainesville, Florida, USA.
9Department of Implementation Science, Wake Forest University, Winston-Salem, North Carolina, USA.
10Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
Abstract
BACKGROUND: Hypertensive disorders of pregnancy (HDP) are a leading cause of maternal and fetal mortality worldwide. Early detection and risk stratification are critical for timely intervention to prevent severe complications such as eclampsia, stroke, and preterm delivery. However, traditional clinical methods often lack the precision needed to identify high-risk individuals effectively. Machine…
Create a free account to keep reading
Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.
Want unlimited research access? See Pro plans
